The business model of acting as a pseudo-generic manufacturer is legally and commercially unsustainable
Early Research in Autoimmune Disease & Fibromyalgia What It Shows and Why Its Limited Fibromyalgia: Early Signals, No Conclusions Some observational reports describe symptom improvements (pain, fatigue, opioid use) in people taking GLP-1 medications, but limitations are consistent: non-randomized design, small samples, and confounding from weight loss, sleep, and metabolic improvements
The fine salt crystals and soothing botanicals are designed for gentle exfoliation suitable for most skin types, including sensitive and acne-prone body skin
While this area of research is still in its early stages, it opens up exciting possibilities for the use of these medications in maintaining bone density and preventing fractures
No hidden charges and no surprises